FDA Alert - Recall: Vasopressin Injection USP, Multiple Dose Vials - Sub-Potency

Sent to you from Drugs.com You received this email because you are subscribed to updates from Drugs.com. Change your notification settings or unsubscribe here.

FDA MedWatch Alert Sent to subscribers of: vasopressin systemic Recall: Vasopressin Injection USP, Multiple Dose Vials - Sub-Potency August 4, 2011 Audience: Risk Manager, Pharmacy. ISSUE: American Regent, Inc. is conducting a nationwide voluntary recall of multiple lots of Vasopressin Injection, USP to the Retail/Hospital level. This product recall was initiated by American Regent, Inc. because some vials may not maintain potency throughout their shelf-life. Potential adverse events after administration of solutions that are below potency limits may include reduced effectiveness. Read more... Get these updates via twitter

Copyright © 2011 Drugs.com. All rights reserved. You received this email because you are subscribed to updates from Drugs.com. Change your notification settings or unsubscribe here.